Skip to Main Content

Paper Details

Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern.
Cell Rep
80
2022
CV3-, CV3-1, CV3-25, S1 subunit, S2 subunit, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 spike (S)-neutralizing, monoclonal antibodies, severe acute respiratory syndrome coronavirus
Author NameAffiliation
Rick K HuangNational Cancer Institute, National Institutes of Health
Pradeep D UchilYale University School of Medicine
Walther MothesYale University School of Medicine
  • 1 - 3

Datasets

Release 1.2